Design and synthesis of DNA-intercalating 9-fluoren-β-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 7, 2004, Pages 1781-1791

  Alcaro, S ^a   Arena, A ^b   Neri, S ^c   Ottana R ^c   Ortuso, F ^a   Pavone, B ^b   Vigorita, M G ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4 TRI O ACETYL BETA O (9 FLUORENYL) DEXTRO ARABINOPYRANOSE; 2,3,4 TRI O ACETYL BETA O (9 FLUORENYL) LEVO ARABINOPYRANOSE; 2,3,4,6 TETRA O ACETYL BETA O (9 FLUORENYL) DEXTRO GLUCOPYRANOSE; ANTHRACYCLINE DERIVATIVE; ANTIVIRUS AGENT; BETA O (9 FLUORENYL) DEXTRO ARABINOPYRANOSE; BETA O (9 FLUORENYL) DEXTRO LYXOPYRANOSE; BETA O (9 FLUORENYL) DEXTRO XYLOPYRANOSE; BETA O (9 FLUORENYL) LEVO ARABINOPYRANOSE; CYTOSTATIC AGENT; GLYCOSIDE; INTERCALATING AGENT; INTERFERON INDUCING AGENT; TILORONE; UNCLASSIFIED DRUG;

ACETYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPROTECTION REACTION; DOSE RESPONSE; DRUG CONFORMATION; DRUG DESIGN; DRUG EFFECT; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NONHUMAN; VIRUS REPLICATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL LINE; DNA; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INTERCALATING AGENTS; INTERFERONS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEOSIDES; PLAQUE ASSAY; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 1542509349     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.12.034     Document Type: Article

References (35)

1. Osorio Y., Ghiasi H. J. Virol. 77:2003;5774.
2. Goodman & Gilman, 'Le basi farmacologiche della terapia', Zanichelli Ed.: Bologna, 1996, IX ed., cap. 51, pp 1203-1254.
3. Arcamone F. Doxorubicin - Anticancer Antibiotics. 1981;Academic Press, New York.
4. Wang H.K., Morris-Natschke S.L., Lee K.H. Med. Res. Rev. 17:1997;367.
5. Pullman B. Molecular mechanisms of specificity in DNA-antitumor drug interactions. Advances in Drug Research, vol. 18. 1989;74-76 Academic Press, New York.
6. Sainz B., Halford W.P. J. Virol. 76:2002;11541.
7. Samuel C.E. Curr. Top. Microbiol. Immunol. 233:1998;125.
8. Vilcek J., Sen J. Interferons and other cytokines. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;375-400 Raven Publishers, Philadelphia, Pa.
9. Fischer J. Biochem. J. 312:1995;215.
10. Fisher J. Gen. Pharmacol. 27:1996;1317.
11. Lullmann-Rauch R. Exp. Toxicol. Pathol. 46:1994;315.
12. Prokopek M. Biochem. Pharmacol. 42:1991;2187.
13. Fisher J. Biochem. J. 315:1996;369.
14. Lullmann-Rauch R. Biochem. Pharmacol. 49:1995;1223.
15. Fenick D.J. J. Med. Chem. 40:1997;2452.
16. Fischer J.F., Harrison A.W., Bundy G.L., Wilkinson K.F., Rush B.D., Ruwart M.J. J. Med. Chem. 34:1991;4140.
17. Kennedy J.F., White C.A. Bioactive Carbohydrates. Chemistry, Biochemistry and Biology. 1983;John Wiley & Sons, New York.
18. Musser J.H., Fügedi P., Anderson M.B. Carbohydrate-based therapeutics. Burger's Medicinal Chemistry and Drug Discovery, vol. I. 4th ed. 1995;902-947 John Wiley & Sons, New York.
19. Simmons A. J. Infect. Dis. 186:2002;71.
20. Hanessian S., Haskell T.H. Antibiotics containing sugars. The carbohydrates - Chemistry and Biochemistry. 2nd ed. 1970;139-200 Academic Press, London.
21. Greene T.W., Wuts P.G.M. Protective groups in Organic Synthesis. 1991;John Wiley & Sons, New York.
22. Kocienski P.J. Protecting groups. 1994;Thieme, Stuttgart.
23. Koenigs W., Knorr E. Ber. Dtsch. Chem. Ges. 34:1901;957.
24. Schmidt R.R. Angew. Chem., Int. Ed. Engl. 25:1986;212.
25. Schmidt R.etal. Horton D. Advances in Carbohydrate Chemistry and Biochemistry. 1994;21-123 Academic Press, London. 50.
26. Schmidt R.R. Synthesis of glycosides. Comprehensive Organic Synthesis. 1991;49-58 Pergamon Press, Oxford.
27. Smits E.etal. J. Chem. Soc., Perkin Trans. I. 1996;2873.
28. Jensen K.J.et al. J. Chem. Soc., Perkin Trans. I. 1993;2119.
29. Olah G.A., Narang S.C. Tetrahedron. 38:1982;2225.
30. Uchiyama T., Hindsgaul O. Synlett. 1996;499.
31. J. Natl. Cancer Inst. 83:1991;757.
32. Still W.C., Tempczyk A., Hawley R.C., Hendrickson T. J. Am. Chem. Soc. 112:1990;6127.
33. Mohamadi F., Richards N.G.J., Guida W.C., Liskamp R., Lipton M., Caufield C., Chang G., Hendrickson T., Still W.C. J. Comput. Chem. 11:1990;440.
34. Private communication.
35. Havell E.A., Vilcek J. Antimicrob. Agents and Chemother. 2:1972;476.